L3Harris Technologies, Inc.
—- Market cap
- —
- Debt
- —
- Cash
- −$1.07B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: LHX stock price vs JNJ: inconclusive — current versus $205.98 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at JNJ's multiple
Implied fair value · at LHX's multiple
Needs LHX P/E.
Snapshot Sep 10, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Higher is better
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
12 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 93% equity / 7% debt · EV / Revenue 7.11x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
L3HARRIS TECHNOLOGIES, INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Johnson & Johnson · implied price per share
Bear
$93.96
Base
$115.89
Bull
$146.14
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe LHX can sustain premium multiples despite weaker margins and ROIC than JNJ, then hold or accumulate selectively; otherwise, the data favors reducing exposure because LHX trades above its P/E fair value, historical band, and DCF range.
LHX trades at $302.07 versus an implied P/E value of $203.42, implying 32.7% downside, and it is above both JNJ implied range floor and its own historical band. The market is also assigning LHX a richer earnings multiple than JNJ even though JNJ has materially stronger margins and ROIC.
Supporting Metrics